Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada

OBJECTIVE: The aim of this study was to assess the cost effectiveness of semaglutide versus dulaglutide, as an add-on to metformin monotherapy, for the treatment of type 2 diabetes (T2D), from a Canadian societal perspective. METHODS: The Swedish Institute for Health Economics Cohort Model of T2D wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansen, Pierre, Håkan-Bloch, Jonas, Liu, Aiden R., Bech, Peter G., Persson, Sofie, Leiter, Lawrence A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861407/
https://www.ncbi.nlm.nih.gov/pubmed/30927241
http://dx.doi.org/10.1007/s41669-019-0131-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861407/
https://www.ncbi.nlm.nih.gov/pubmed/30927241
http://dx.doi.org/10.1007/s41669-019-0131-6

Ejemplares similares